Global Pruritus Therapeutics Market Research Report 2017 Opportunities, Product Types, Applications, Forecast to 2022

Request for a SAMPLE REPORT

Fill up your details below and get the sample report for FREE

 Published Date : Dec-2017   |    Format :PDF   |    Number of Pages : 124
In the last several years, global market of Pruritus Therapeutics developed smoothly, with an average growth rate of 4.8%. In 2016, global consumption value of Pruritus Therapeutics is nearly 10.8 billion USD.

This report studies Pruritus Therapeutics in Global market, especially in North America, Europe, China, Rest of Asia, focuses on top manufacturers in global market, with revenue and market share for each manufacturer, covering
J&J
Abbott
Amgen
LEO Pharma
Novartis
Bayer
Pfizer
UCB Pharma
GlaxoSmithKline
Galderma
Huapont

Market Segment by Regions, this report splits Global into several key Regions, with revenue, market share and growth rate of Pruritus Therapeutics in these regions, from 2012 to 2022 (forecast), like
North America
Europe
Asia-Pacific
South America
Middle East and Africa

Split by Product Types, with revenue market share and growth rate of each type, can be divided into
Antihistamines
Corticosteroids
Calcineurin Inhibitors
Other

Split by applications, this report focuses on revenue market share and growth rate of Pruritus Therapeutics in each application, can be divided into
External Use
Oral
Injection

1 Pruritus Therapeutics Market Overview	1
1.1 Product Overview and Scope of Pruritus Therapeutics	1
1.2 Pruritus Therapeutics Segment by Types and Drugs Types	2
1.2.1 Global Pruritus Therapeutics Revenue and Growth (%) Comparison by Types (2012-2022)	2
1.2.2 Global Pruritus Therapeutics Revenue Market Share (%) by Types in 2016	2
1.2.3 Corticosteroids	3
1.2.4 Antihistamines	3
1.2.5 Calcineurin Inhibitors	4
1.3 Pruritus Therapeutics Segment by Applications	4
1.3.1 Global Pruritus Therapeutics Revenue Comparison by Applications (2012-2022)	4
1.3.2 External Use	5
1.3.3 Oral	6
1.3.4 Injection	6
1.4 Pruritus Therapeutics Market by Regions	7
1.4.1 Global Pruritus Therapeutics Market Size and Growth (%) Comparison by Regions	7
1.4.2 North America Status and Prospect (2012-2022)	7
1.4.3 Asia-Pacific Status and Prospect (2012-2022)	8
1.4.4 Europe Status and Prospect (2012-2022)	9
1.4.5 South America Status and Prospect (2012-2022)	10
1.4.6 Middle East and Africa Status and Prospect (2012-2022)	11
1.5 Global Market Size (Value) of Pruritus Therapeutics (2012-2022)	12
2 Global Pruritus Therapeutics Market Competition by Manufacturers	13
2.1 Global Pruritus Therapeutics Revenue and Share by Manufacturers (2016 and 2017)	13
2.2 Global Pruritus Therapeutics Gross Profit and Share by Manufacturers (2016 and 2017)	15
2.3 Global Pruritus Therapeutics Gross Margin of Manufacturers (2016 and 2017)	18
2.4 Manufacturers Pruritus Therapeutics Headquarters, Founded Time	20
2.5 Pruritus Therapeutics Market Competitive Situation and Trends	21
2.5.1 Pruritus Therapeutics Market Concentration Rate	21
2.5.2 Pruritus Therapeutics Market Share of Top 3 and Top 5 Manufacturers	22
2.5.3 Mergers & Acquisitions, Expansion	23
3 Global Pruritus Therapeutics Revenue (Value) by Regions (2012-2017)	24
3.1 Global Pruritus Therapeutics Revenue (Value) and Market Share by Regions (2012-2017)	24
3.2 Global Pruritus Therapeutics Gross Profit and Market Share by Regions (2012-2017)	26
3.3 Global Pruritus Therapeutics Revenue and Gross Margin (2012-2017)	28
3.4 North America Pruritus Therapeutics Revenue and Gross Margin (2012-2017)	28
3.5 Europe Pruritus Therapeutics Revenue and Gross Margin (2012-2017)	28
3.6 Asia-Pacific Pruritus Therapeutics Revenue and Gross Margin (2012-2017)	29
3.7 South America Pruritus Therapeutics Revenue and Gross Margin (2012-2017)	29
3.8 Middle East and Africa Pruritus Therapeutics Revenue and Gross Margin (2012-2017)	29
4 Global Pruritus Therapeutics Revenue Trend by Type	30
4.1 Global Pruritus Therapeutics Revenue and Market Share by Product Catalog (2012-2017)	30
4.2 Global Pruritus Therapeutics Revenue Growth by Type (2012-2017)	32
5 Global Pruritus Therapeutics Market Analysis by Applications	33
5.1 Global Pruritus Therapeutics Revenue and Market Share by Applications (2012-2017)	33
5.2 Global Pruritus Therapeutics Revenue Growth Rate (%) by Applications (2012-2017)	35
6 Analysis of Pruritus Therapeutics Industry Key Manufacturers	36
6.1 J&J	36
6.1.1 Company Profile	36
6.1.2 Product Information	37
6.1.3 Revenue, Gross Profit and Gross Margin	37
6.2 Abbott	38
6.2.1 Company Profile	38
6.2.2 Product Information	39
6.2.3 Revenue, Gross Profit and Gross Margin	39
6.3 Amgen	39
6.3.1 Company Profile	39
6.3.2 Product Information	40
6.3.3 Revenue, Gross Profit and Gross Margin	41
6.4 LEO Pharma	41
6.4.1 Company Profile	41
6.4.2 Product Information	42
6.4.3 Revenue, Gross Profit and Gross Margin	42
6.5 Novartis	43
6.5.1 Company Profile	43
6.5.2 Product Information	44
6.5.3 Revenue, Gross Profit and Gross Margin	44
6.6 Bayer	45
6.6.1 Company Profile	45
6.6.2 Product Information	46
6.6.3 Revenue, Gross Profit and Gross Margin	46
6.7 Pfizer	47
6.7.1 Company Profile	47
6.7.2 Product Information	48
6.7.3 Revenue, Gross Profit and Gross Margin	48
6.8 UCB Pharma	49
6.8.1 Company Profile	49
6.8.2 Product Information	50
6.8.3 Revenue, Gross Profit and Gross Margin	50
6.9 GlaxoSmithKline	51
6.9.1 Company Profile	51
6.9.2 Product Information	52
6.9.3 Revenue, Gross Profit and Gross Margin	52
6.10 Galderma	53
6.10.1 Company Profile	53
6.10.2 Product Information	54
6.10.3 Revenue, Gross Profit and Gross Margin	54
6.11 Huapont	55
6.11.1 Company Profile	55
6.11.2 Product Information	56
6.11.3 Revenue, Gross Profit and Gross Margin	57
7 Pruritus Therapeutics Manufacturing Cost Analysis	58
7.1 Pruritus Therapeutics R&D Cost Analysis	58
7.1.1 Clinical Phase Costs	59
7.1.2 Capitalized Costs	60
7.2 Proportion of Manufacturing Cost Structure	61
7.2.1 Raw Materials	61
7.2.2 Labor Cost	62
7.2.3 Manufacturing Expenses	67
7.2.4 Other Costs Analysis	67
7.3 Manufacturing Process Analysis of Pruritus Therapeutics	73
8 Industrial Chain, Sourcing Strategy and Downstream Buyers	74
8.1 Pruritus Therapeutics Industrial Chain Analysis	74
8.2 Upstream Raw Materials Sourcing	75
8.3 Downstream Buyers	75
9 Marketing Strategy Analysis, Distributors/Traders	78
9.1 Marketing Channel	78
9.1.1 Direct Marketing	78
9.1.2 Indirect Marketing	79
9.1.3 Marketing Channel Development Trend	79
9.2 Market Positioning	79
9.2.1 Pricing Strategy	79
9.2.2 Brand Strategy	81
9.3 Distributors/Traders List	84
10 Market Effect Factors Analysis	86
10.1 Market Drivers	86
10.2 Consumer Needs/Customer Preference Change	86
10.3 Economic/Political Environmental Change	87
11 Global Pruritus Therapeutics Market Forecast (2017-2022)	96
11.1 Global Pruritus Therapeutics Revenue Forecast (2017-2022)	96
11.2 Global Pruritus Therapeutics Revenue Forecast by Regions (2017-2022)	96
11.2.1 North America Pruritus Therapeutics Revenue Forecast (2017-2022)	98
11.2.2 Europe Pruritus Therapeutics and Revenue Forecast (2017-2022)	99
11.2.3 Asia-Pacific Pruritus Therapeutics Revenue Forecast (2017-2022)	100
11.2.4 South America Pruritus Therapeutics Revenue Forecast (2017-2022)	101
11.2.5 Middle East and Africa Pruritus Therapeutics Revenue Forecast (2017-2022)	102
11.3 Global Pruritus Therapeutics Revenue Forecast by Type (2017-2022)	102
11.4 Global Pruritus Therapeutics Revenue Forecast by Application (2017-2022)	103
12 Research Findings and Conclusion	105
13 Methodology and Data Source	106
13.1 Methodology/Research Approach	106
13.1.1 Research Programs/Design	106
13.1.2 Market Size Estimation	107
13.1.3 Market Breakdown and Data Triangulation	108
13.2 Data Source	109
13.2.1 Secondary Sources	109
13.2.2 Primary Sources	110
13.3 Disclaimer	111
13.4 Author List	112

 
List of Tables and Figures

Figure Picture of Pruritus Therapeutics	1
Table Global Pruritus Therapeutics Revenue (M USD) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)	2
Figure Global Revenue Market Share of Pruritus Therapeutics by Types in 2016	2
Figure Product Picture of Corticosteroids	3
Figure Product Picture of Antihistamines	3
Figure Product Picture of Calcineurin Inhibitors	4
Table Global Pruritus Therapeutics Revenue (M USD) Comparison by Applications (2012-2022)	4
Figure Pruritus Therapeutics Revenue Market Share by Applications in 2016	5
Figure External Use Examples	5
Figure Oral Examples	6
Figure Injection Examples	6
Table Global Market Pruritus Therapeutics Revenue (M USD) Comparison by Regions 2012-2022	7
Figure North America Pruritus Therapeutics Revenue (M USD) and Growth Rate (2012-2022)	7
Figure Asia-Pacific Pruritus Therapeutics Revenue (M USD) and Growth Rate (2012-2022)	8
Figure Europe Pruritus Therapeutics Revenue (M USD) and Growth Rate (2012-2022)	9
Figure South America Pruritus Therapeutics Revenue (M USD) and Growth Rate (2012-2022)	10
Figure Middle East and Africa Pruritus Therapeutics Revenue (M USD) and Growth Rate (2012-2022)	11
Figure Global Pruritus Therapeutics Revenue (M USD) and Growth Rate (2012-2022)	12
Table Global Pruritus Therapeutics Revenue (M USD) by Manufacturers (2016 and 2017)	13
Table Global Pruritus Therapeutics Revenue Share by Manufacturers (2016 and 2017)	13
Figure 2016 Global Pruritus Therapeutics Revenue Share by Manufacturers	14
Figure 2017 Global Pruritus Therapeutics Revenue Share by Manufacturers	15
Table Global Pruritus Therapeutics Gross Profit (M USD) of Key Manufacturers (2016 and 2017)	15
Table Global Pruritus Therapeutics Gross Profit Share by Manufacturers (2016 and 2017)	16
Figure 2016 Pruritus Therapeutics Gross Profit Share by Manufacturers	17
Figure 2017 Pruritus Therapeutics Gross Profit Share by Manufacturers	18
Table Global Market Pruritus Therapeutics Gross Margin of Key Manufacturers (2016 and 2017)	18
Figure Global Market Pruritus Therapeutics Gross Margin of Key Manufacturers in 2016	19
Figure Global Market Pruritus Therapeutics Gross Margin of Key Manufacturers in 2017	20
Table Manufacturers Pruritus Therapeutics Headquarters and Founded Time	20
Figure Pruritus Therapeutics Revenue Market Concentration Rate in 2016	21
Figure Pruritus Therapeutics Revenue Market Share of Top 3 Manufacturers in 2016	22
Figure Pruritus Therapeutics Revenue Market Share of Top 5 Manufacturers in 2016	22
Table Mergers & Acquisitions, Expansion	23
Table Global Pruritus Therapeutics Revenue (M USD) by Regions (2012-2017)	24
Table Global Pruritus Therapeutics Revenue Market Share by Regions (2012-2017)	24
Figure 2012-2017 Global Pruritus Therapeutics Revenue Market Share by Regions	25
Table 2016 Global Pruritus Therapeutics Revenue Market Share by Regions	25
Table Global Pruritus Therapeutics Gross Profit (M USD) by Regions (2012-2017)	26
Figure Global Pruritus Therapeutics Gross Profit and Market Share by Regions (2012-2017)	26
Figure 2012-2017 Global Pruritus Therapeutics Gross Profit Market Share by Regions	27
Table 2016 Global Pruritus Therapeutics Gross Profit Market Share by Regions	27
Table Global Pruritus Therapeutics Revenue (M USD) and Gross Margin (2012-2017)	28
Table North America Pruritus Therapeutics Revenue (M USD) and Gross Margin (2012-2017)	28
Table Europe Pruritus Therapeutics Revenue (M USD) and Gross Margin (2012-2017)	28
Table Asia-Pacific Pruritus Therapeutics Revenue (M USD) and Gross Margin (2012-2017)	29
Table South America Pruritus Therapeutics Revenue (M USD) and Gross Margin (2012-2017)	29
Table Middle East and Africa Pruritus Therapeutics Revenue (M USD) and Gross Margin (2012-2017)	29
Table Global Pruritus Therapeutics Revenue (M USD) by Product Catalog (2012-2017)	30
Table Global Pruritus Therapeutics Revenue Share (%) by Product Catalog (2012-2017)	30
Figure Revenue Market Share (%) of Pruritus Therapeutics by Product Catalog (2012-2017)	31
Figure 2016 Revenue Market Share (%) of Pruritus Therapeutics by Product Catalog	31
Figure Global Pruritus Therapeutics Revenue Growth (%) by Type (2012-2017)	32
Table Global Pruritus Therapeutics Revenue (M USD) by Applications (2012-2017)	33
Table Global Pruritus Therapeutics Revenue Market Share (%) by Applications (2012-2017)	33
Figure Global Pruritus Therapeutics Revenue Market Share (%) by Applications (2012-2017)	34
Figure Global Pruritus Therapeutics Revenue Market Share (%) by Applications in 2016	34
Table Global Pruritus Therapeutics Revenue Growth Rate (%) by Applications (2012-2017)	35
Figure Global Pruritus Therapeutics Revenue Growth Rate (%) by Applications (2012-2017)	35
Table J&J Company Profile	36
Figure Pruritus Therapeutics Product Introduction of J&J	37
Table Pruritus Therapeutics Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of J&J 2016-2017	37
Table Abbott Company Profile	38
Figure Pruritus Therapeutics Product Introduction of Abbott	39
Table Pruritus Therapeutics Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Abbott 2016-2017	39
Table Amgen Company Profile	39
Figure Pruritus Therapeutics Product Introduction of Amgen	40
Table Pruritus Therapeutics Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Amgen 2016-2017	41
Table LEO Pharma Company Profile	41
Figure Pruritus Therapeutics Product Introduction of LEO Pharma	42
Table Pruritus Therapeutics Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of LEO Pharma 2016-2017	42
Table Novartis Company Profile	43
Figure Pruritus Therapeutics Product Introduction of Novartis	44
Table Pruritus Therapeutics Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Novartis 2016-2017	44
Table Bayer Company Profile	45
Figure Pruritus Therapeutics Product Introduction of Bayer	46
Table Pruritus Therapeutics Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Bayer 2016-2017	46
Table Pfizer Company Profile	47
Figure Pruritus Therapeutics Product Introduction of Pfizer	48
Table Pruritus Therapeutics Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Pfizer 2016-2017	48
Table UCB Pharma Company Profile	49
Figure Pruritus Therapeutics Product Introduction of UCB Pharma	50
Table Pruritus Therapeutics Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of UCB Pharma 2016-2017	50
Table GlaxoSmithKline Company Profile	51
Figure Pruritus Therapeutics Product Introduction of GlaxoSmithKline	52
Table Pruritus Therapeutics Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of GlaxoSmithKline 2016-2017	52
Table Galderma Company Profile	53
Figure Pruritus Therapeutics Product Introduction of Galderma	54
Table Pruritus Therapeutics Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Galderma 2016-2017	54
Table Huapont Company Profile	55
Figure Pruritus Therapeutics Product Introduction of Huapont	56
Table Pruritus Therapeutics Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Huapont 2016-2017	57
Figure Typical Phases from Research to the Market for a Drug Candidate	59
Table Out-of-pocket Preclinical and Clinical Period Cost per Investigational Pruritus Therapeutics Compound	60
Table Capitalized Preclinical and Clinical Period Costs per Investigational Pruritus Therapeutics Compound	61
Table Manufacturing Cost Structure of Pruritus Therapeutics	61
Figure Brazil Overview of Average Monthly Wages 2015-2016 (BRL/Month)	62
Figure Argentina Overview of Average Monthly Wages 2012-2016 (ARS/Month)	62
Figure Mexico Overview of Average Monthly Wages 2012-2016(MXN/Day)	63
Figure USA Labor Cost Analysis	63
Figure Cost of Employing a Factory Worker	65
Figure 2016 Estimated Labour Costs for the Whole Economy in EuropeR	66
Figure Monthly Minimum Wages in Asia 2016	66
Figure China Labor Costs	67
Table Average Price of Electricity to Ultimate Customers	68
Figure Electricity Prices for Household Consumers in 2016	70
Figure Summary of the Driving Assumptions	71
Figure Industrial Electric Rates 2016 (PER KWH)	71
Figure Manufacturing Process Analysis of Pruritus Therapeutics	73
Figure Pruritus Therapeutics Industrial Chain Analysis	74
Table Major Buyers of Pruritus Therapeutics	75
Figure Marketing Channel for Pruritus Therapeutics	78
Table Distributors/Traders List	84
Table Market Drivers of Pruritus Therapeutics	86
Figure Global GDP Growth Rate for 2015	87
Figure US GDP 2006-2016 (Billion USD)	88
Figure US CPI Change 2016-2017	89
Figure EU GDP 2006-2016 (Billion USD)	89
Figure EU CPI Change 2012-2016	90
Figure Germany GDP 2006-2016 (Billion USD)	90
Figure Germany CPI Change 2016-2017	91
Figure UK GDP 2006-2016 (Billion USD)	91
Figure UK CPI Change 2016-2017	92
Figure Italy GDP 2006-2016 (Billion USD)	92
Figure Italy CPI Change 2016-2017	93
Figure Japan GDP 2006-2016 (Billion USD)	93
Figure Japan CPI Change 2012-2016	94
Figure China GDP 2006-2016 (Billion USD)	94
Figure China CPI Change 2016-2017	95
Figure Global Pruritus Therapeutics Revenue (M USD) and Growth Rate Forecast (2017-2022)	96
Table Global Pruritus Therapeutics Revenue (M USD) Forecast by Regions (2017-2022)	96
Figure Global Pruritus Therapeutics Revenue Forecast by Regions (2017-2022)	97
Figure North America Pruritus Therapeutics Revenue (M USD) and Growth Rate (%) Forecast (2017-2022)	98
Figure Europe Pruritus Therapeutics Revenue (M USD) and Growth Rate (%) Forecast (2017-2022)	99
Figure Asia-Pacific Pruritus Therapeutics Revenue (M USD) and Growth Rate (%) Forecast (2017-2022)	100
Figure South America Pruritus Therapeutics Revenue (M USD) and Growth Rate (%) Forecast (2017-2022)	101
Figure Middle East and Africa Pruritus Therapeutics Revenue (M USD) and Growth Rate (%) Forecast (2017-2022)	102
Table Global Pruritus Therapeutics Revenue (M USD) Forecast by Product Catalog (2017-2022)	102
Figure Global Pruritus Therapeutics Revenue Market Share (%) Forecast by Product Catalog (2017-2022)	103
Table Global Pruritus Therapeutics Revenue (M USD) Forecast by Application (2017-2022)	103
Figure Global Pruritus Therapeutics Revenue Forecast by Application (2017-2022)	104
Table Research Programs/Design for This Report	106
Figure Bottom-up and Top-down Approaches for This Report	108
Figure Data Triangulation	109
Table Key Data Information from Secondary Sources	110
Table Key Data Information from Primary Sources	111



Latest News

25-Feb-2019 | Medical Devices

Launch Of Symjepi Epinephrine Syringe To Boost The Syringe Market Growth In US

A rising burden of chronic diseases has been observed all across the world, which, in turn, has elevated the usage of syringes. Overall, the global syringe market is anticipated to observe vigorous ...

25-Feb-2019 | Electrical & Electronic Device

Launch Of Xiaomi Set-Top Box To Power The Global 4K Set-Top Box Market

While smart TVs are turning out to be much more widespread these days, a number of consumers still choose to opt for normal TVs and then employ smart streaming set top box with them. Popular choice ...

13-Feb-2019 | Software

Bioinspired Artificial Bug Eye Creation Is A Baton For Global Autonomous Car Market

After looking at the different eye lens structures of the animals and humans, the researchers have decided on creating a sharp image using its design. The compound eyes of the bugs are currently be ...

13-Feb-2019 | Consumer Goods & Retailing

Cafe X’s $12 Million “Seed-1” Round To Boost The Global Coffee Market

Cafe X, a company engaged in building robot baristas, is about to raise a $12 Million “Seed-1” round. Recently, Crunchbase News broke the story when it came across regulatory f ...

05-Feb-2019 | Chemicals & Materials

Clinically Produced Cells Change The Horizon Of Global Bone Cement And Glue Market

The group of researchers from the New York Stem Cell Foundation Research Institute published an article in Stem Cell Research and Therapy where the details regarding the clinical ...